Articles
Clinical Neuropsychopharmacology and Addiction
Deaths Involving Gabapentin and Pregabalin, Scotland, 2000–2024: A Descriptive Account
John Martin Corkery, Amira Guirguis, Fabrizio Schifano
2026, 2(2): 7. doi: 10.53941/cna.2026.100007
Epigenetic Mechanisms of Psychedelics in Addiction: Emerging Evidence and Therapeutic Potential
Antonio Inserra, Francesca Zoratto, Mauro Pettorruso, Giovanni Martinotti
2026, 2(2): 6. doi: 10.53941/cna.2026.100006
Can Substance-Induced Psychoses (SIP) Shed Light on the Paradigm of Schizophrenia?
Alessio Mosca, Filippo Maria Ferro
2026, 2(1): 5. doi: 10.53941/cna.2026.100005
Aripiprazole Long Acting and Clozapine: Between Efficacy and Tolerability
Luca Persico, Ludovica Di Sante, Michele Xynelis, Andrea Miuli, Alessio Mosca, Mauro Pettorruso
2026, 2(1): 4. doi: 10.53941/cna.2026.100004
Brexpiprazole in the Management of Schizophrenia and Comorbid Substance Use Disorders: A Narrative Review of Efficacy, Safety, and Real-World Evidence (2020–2026)
Miriam Olivola, Nicolaja Girone, Andrea Crippa, Monica Macellaro, Vassilis Martiadis, Fabiola Raffone, Tiziano Prodi, Natascia Brondino, Roberta Anniverno, Bernardo Dell’Osso
2026, 2(1): 3. doi: 10.53941/cna.2026.100003
Improved Migraine Disability, Sleep Quality, and Well-Being in Individuals with Chronic Migraine Self-Administering Artisanal or Industrial Full-Spectrum Cannabidiol-Rich Oils: An Observational Cohort Study
Linério Ribeiro de Novais Júnior, Larissa Mendes da Silva, Vicente Meneguzzo, Suelen de Souza Ramos, Lara Rodrigues da Rosa, Tiago Odilio de Souza, João Victor Simão, Alisson Reuel da Silva, Josiel Mack, Kelser de Souza Kock, Mariana Pereira de Souza Goldim, Antonio Inserra, Rafael Mariano de Bitencourt
2026, 2(1): 2. doi: 10.53941/cna.2026.100002
Ketamine-Related Deaths Registered in Scotland 2013–2024
John Martin Corkery, Amira Guirguis, Fabrizio Schifano
2026, 2(1): 1. doi: 10.53941/cna.2026.100001
Psychopathology and Psychiatric Risks Linked to High-Potency Cannabis, Crack Cocaine and Novel Psychoactive Substances
Tommaso Piro, Alessia Santeusanio, Federica Marsico, Arianna Rosati, Andrea Miuli, John Martin Corkery, Giovanni Martinotti
2025, 1(1): 8. doi: 10.53941/cna.2025.100008
Retrospective Observations from a Pilot Study on the Feasibility and Safety of Medication Reduction or Withdrawal in Children with Autism Spectrum Disorder Taking Cannabidiol-Rich Oil
Alysson Madruga de Liz, Antonio Inserra, Antonella Campanale, Linério Ribeiro de Novais, Jr., Raquel Alberti, Diogo Alexandre Gomes, Kelser de Souza Kock, Rafael Mariano de Bitencourt, Paulo César Trevisol Bittencourt
2025, 1(1): 7. doi: 10.53941/cna.2025.100007
Novel Perspectives for Glutamatergic Strategies, Psychedelics and Antipsychotic Augmentation in Treatment Resistant Depression: A Narrative Review
Clara Cavallotto, Stefania Chiappini, Andrea Miuli, Giacomo d'Andrea, Alessio Mosca, Carlotta Marrangone, Rita Allegretti, Serena Panichella, Antonio D'Attilio, Giovanna Mammarella, Luca Persico, Alessia Santeusanio, Gianfranco Tamagnini, Mauro Pettorruso, Giovanni Martinotti
2025, 1(1): 6. doi: 10.53941/cna.2025.100006
Miriam Olivola, Filippo Mazzoni, Tiziano Prodi, Giada Versaci, Giovanni Carnevale Miacca, Alessandro Guffanti, Vassilis Martiadis, Natascia Brondino, Bernardo Maria Dell’Osso
2025, 1(1): 5. doi: 10.53941/cna.2025.100005
Valerio Ricci
2025, 1(1): 4. doi: 10.53941/cna.2025.100004
Alessandro Matteo Sileoni, Elena Teresa Turco, Francesco Semeraro, Clara Cavallotto, Alessio Mosca, Stefania Chiappini, Giovanni Martinotti
2025, 1(1): 3. doi: 10.53941/cna.2025.100003
Filippo Mazzoni, Giovanni Carnevale Miacca, Alessandro Guffanti, Vassilis Martiadis, Bernardo Maria Dell’Osso, Natascia Brondino, Miriam Olivola
2025, 1(1): 2. doi: 10.53941/cna.2025.100002
Giovanni Martinotti, Stefania Chiappini
2025, 1(1): 1. doi: 10.53941/cna.2025.100001
Suite 4002 Level 4, 447 Collins Street, Melbourne, Victoria 3000, Australia
General Inquiries: info@sciltp.com